Prometheus Laboratories Inc. drugs
5 results
Imuran (azathioprine)
(azathioprine)Prometheus Laboratories Inc.
Usage: IMURAN is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. It may be used alongside aspirin, NSAIDs, or low-dose glucocorticoids, but combined use with other DMARDs has not been studied.
Lotronex (alosetron hydrochloride)
(alosetron hydrochloride)Prometheus Laboratories Inc.
Usage: LOTRONEX is indicated for women with severe diarrhea-predominant irritable bowel syndrome (IBS) who have chronic symptoms lasting over six months, no identified gastrointestinal abnormalities, and inadequate response to conventional treatments. It is restricted due to potential serious gastrointestinal adverse reactions, with benefits not established in men.
Proleukin (aldesleukin)
(aldesleukin)Prometheus Laboratories Inc.
Usage: Proleukin® (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma and metastatic melanoma. Patient selection is crucial, emphasizing the need for screening and assessment of performance status to optimize response rates and minimize toxicity.
Ridaura (auranofin)
(auranofin)Prometheus Laboratories Inc.
Usage: RIDAURA (auranofin) is indicated for adults with active rheumatoid arthritis who have not responded adequately to or are intolerant of nonsteroidal anti-inflammatory drugs (NSAIDs). It should be part of a comprehensive treatment program and is particularly beneficial in patients with early-stage active synovitis.
Zyloprim (allopurinol)
(allopurinol)Prometheus Laboratories Inc.
Usage: ZYLOPRIM is indicated for managing gout symptoms, hyperuricemia in patients undergoing cancer treatment, and recurrent calcium oxalate stones linked to elevated uric acid excretion. Its use should be tailored to each patient, considering individual pharmacokinetics. Not for asymptomatic hyperuricemia.